Extensive culturomics of 8 healthy samples enhances metagenomics efficiency.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
03
05
2019
accepted:
22
09
2019
entrez:
22
10
2019
pubmed:
22
10
2019
medline:
17
3
2020
Statut:
epublish
Résumé
Molecular approaches have long led to the assumption that the human gut microbiota is dominated by uncultivable bacteria. The recent advent of large-scale culturing methods, and in particular that of culturomics have demonstrated that these prokaryotes can in fact be cultured. This is increasing in a dramatic manner the repertoire of commensal microbes inhabiting the human gut. Following eight years of culturomics approach applied on more than 900 samples, we propose herein a remake of the pioneering study applying a dual approach including culturomics and metagenomics on a cohort of 8 healthy specimen. Here we show that culturomics enable a 20% higher richness when compared to molecular approaches by culturing 1 archaeal species and 494 bacterial species of which 19 were new taxa. Species discovered as a part of previous culturomics studies represent 30% of the cultivated isolates, while sequences derived from these new taxa enabled to increase by 22% the bacterial richness retrieved by metagenomics. Overall, 67% of the total reads generated were covered by cultured isolates, significantly reducing the hidden content of sequencing methods compared to the pioneering study. By redefining culture conditions to recover microbes previously considered fastidious, there are greater opportunities than ever to eradicate metagenomics dark matter.
Identifiants
pubmed: 31634343
doi: 10.1371/journal.pone.0223543
pii: PONE-D-19-12468
pmc: PMC6802823
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0223543Commentaires et corrections
Type : ExpressionOfConcernIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Microbiol. 2016 Nov 07;1:16203
pubmed: 27819657
BMC Microbiol. 2018 Oct 24;18(1):157
pubmed: 30355340
Anaerobe. 2015 Dec;36:73-8
pubmed: 26514403
BMC Biol. 2009 Nov 03;7:72
pubmed: 19886985
Clin Microbiol Infect. 2019 Apr 12;:null
pubmed: 30986553
Nature. 2016 May 04;533(7604):543-546
pubmed: 27144353
Clin Infect Dis. 2018 Feb 10;66(5):645-650
pubmed: 29020328
Int J Antimicrob Agents. 2019 Apr;53(4):355-361
pubmed: 30472293
Clin Microbiol Infect. 2012 Dec;18(12):1185-93
pubmed: 23033984
Eur J Clin Microbiol Infect Dis. 2013 Aug;32(8):1099
pubmed: 23430196
Eur J Clin Microbiol Infect Dis. 2015 Mar;34(3):561-70
pubmed: 25348607
Infect Dis Clin North Am. 2015 Mar;29(1):109-22
pubmed: 25677705
Int J Syst Evol Microbiol. 2013 Jul;63(Pt 7):2600-6
pubmed: 23264499
Microbiome. 2017 Aug 16;5(1):86
pubmed: 28810907
BMC Bioinformatics. 2012 Feb 14;13:31
pubmed: 22333067
PLoS One. 2019 Jan 10;14(1):e0210073
pubmed: 30629606
Int J Antimicrob Agents. 2014 Aug;44(2):117-24
pubmed: 25063078
Appl Environ Microbiol. 2014 Dec;80(24):7659-66
pubmed: 25281372
PLoS Pathog. 2012;8(5):e1002742
pubmed: 22693451
Clin Microbiol Rev. 2015 Jan;28(1):237-64
pubmed: 25567229
Gigascience. 2019 Mar 1;8(3):
pubmed: 30698687
Microbiome. 2018 May 24;6(1):94
pubmed: 29793532
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Physiol Rev. 2010 Jul;90(3):859-904
pubmed: 20664075
Int J Syst Evol Microbiol. 2014 Feb;64(Pt 2):346-51
pubmed: 24505072
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Appl Environ Microbiol. 2018 Sep 17;84(19):
pubmed: 30030229
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712